4.7 Article

Executive Summary: The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

期刊

CLINICAL INFECTIOUS DISEASES
卷 53, 期 7, 页码 617-630

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cir625

关键词

-

资金

  1. IDSA
  2. Johnson & Johnson Pharmaceuticals
  3. Cubist
  4. Merck
  5. Sanofi Pasteur
  6. Astellas
  7. National Institutes of Health
  8. Robert Wood Johnson
  9. Wyeth Pharmaceuticals
  10. GlaxoSmithKline

向作者/读者索取更多资源

Evidenced-based guidelines for management of infants and children with community-acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and investigators representing community pediatrics, public health, and the pediatric specialties of critical care, emergency medicine, hospital medicine, infectious diseases, pulmonology, and surgery. These guidelines are intended for use by primary care and subspecialty providers responsible for the management of otherwise healthy infants and children with CAP in both outpatient and inpatient settings. Site-of-care management, diagnosis, antimicrobial and adjunctive surgical therapy, and prevention are discussed. Areas that warrant future investigations are also highlighted.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据